NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,696,000 | +817.0% | 75,369 | +567.0% | 0.00% | – |
| Q3 2014 | $294,000 | -84.4% | 11,300 | -80.2% | 0.00% | -100.0% |
| Q2 2014 | $1,890,000 | -34.1% | 57,191 | -40.4% | 0.00% | -50.0% |
| Q1 2014 | $2,870,000 | +17.1% | 95,971 | +18.9% | 0.00% | 0.0% |
| Q4 2013 | $2,450,000 | +13.6% | 80,730 | +19.1% | 0.00% | 0.0% |
| Q3 2013 | $2,157,000 | +19509.1% | 67,797 | +9585.3% | 0.00% | – |
| Q2 2013 | $11,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,525 | $11,219,000 | 4.40% |
| Palo Alto Investors LP | 1,699,562 | $44,189,000 | 3.30% |
| FCG ADVISORS, LLC | 133,504 | $4,116,000 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,726,824 | $44,897,000 | 1.89% |
| Rhenman & Partners Asset Management AB | 224,000 | $5,824,000 | 1.70% |
| BENDER ROBERT & ASSOCIATES | 75,090 | $1,952,000 | 1.36% |
| Penn Capital Management Company, LLC | 1,035,144 | $26,914,000 | 1.12% |
| NEXT CENTURY GROWTH INVESTORS LLC | 1,066,148 | $27,719,000 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 391,281 | $10,173,000 | 0.98% |
| SCHOLTZ & COMPANY, LLC | 31,990 | $832,000 | 0.82% |